hepat
b
viru
hbv
infect
common
chronic
viral
infect
world
estim
billion
peopl
infect
million
chronic
carrier
viru
due
insuffici
immun
respons
individu
hbv
infect
develop
chronic
hepat
eventu
result
liver
cirrhosi
hepatocellular
carcinoma
hcc
underli
mechan
hbvinduc
chronic
hepat
remain
unclear
sever
studi
indic
dendrit
cell
dc
function
impair
patient
chronic
hepat
b
dc
potent
antigenpres
cell
apc
present
antigen
cell
activ
naiv
cell
multipl
receptor
molecul
surfac
dc
includ
tolllik
receptor
tlr
ctype
lectin
receptor
clr
particip
recognit
uptak
pathogen
regul
express
costimulatori
molecul
particular
dcspecif
grab
nonintegrin
dcsign
import
clr
mainli
express
surfac
matur
immatur
dc
dcsign
play
import
role
recognit
pathogenassoci
molecular
pattern
pamp
moreov
previou
studi
shown
dcsign
involv
immun
escap
multipl
pathogen
microorgan
includ
ebola
viru
hepat
c
viru
hcv
dengu
fever
viru
cytomegaloviru
cmv
sarscoronaviru
mycobacterium
tuberculosi
helicobact
pylori
fungu
parasit
unfortun
mechan
behind
immun
escap
mediat
dcsign
remain
unclear
may
dcsign
directli
recogn
mannos
oligosaccharid
found
viral
envelop
hbv
modif
mannos
oligosaccharid
viral
envelop
hbv
could
potenti
evad
host
immun
system
inde
shown
dcsign
recogn
wildtyp
hbv
recogn
highmannos
type
hbv
produc
applic
class
inhibitor
kifunensin
moreov
previou
studi
found
highmannos
type
hbv
could
promot
matur
dc
increas
secret
effect
stimul
prolifer
allogen
lymphocyt
effect
block
specif
antidcsign
antibodi
therefor
demannosyl
appear
benefici
hbv
escap
dcsign
recognit
avoid
consequ
immun
elimin
demannosyl
glycoprotein
occur
famili
mannosidas
trim
mannan
noligosaccharid
human
class
includ
er
three
golgi
name
ia
ib
ic
gener
firstli
trim
trim
residu
gener
process
depend
vari
level
mannosidas
subtyp
differ
cell
type
glycosyl
site
surfac
hbv
envelop
protein
could
glycosyl
host
therefor
surpris
hbv
infect
previous
shown
upregul
express
er
degradationenhanc
edem
order
increas
demannosyl
howev
studi
investig
effect
hbv
express
class
peroxisom
prolifer
activatedreceptor
ppar
group
ligandactiv
nuclear
transcript
factor
may
involv
express
hbv
infect
inde
tumor
necrosi
shown
downregul
express
increas
express
highmannos
type
proteoglycan
revers
activ
ppar
signal
pathway
base
result
previou
studi
hypothes
hbv
could
promot
demannosyl
viral
protein
increas
express
host
cell
turn
dcsign
longer
recogn
hbv
glycoprotein
coat
allow
viru
escap
immun
attack
present
studi
investig
effect
hbv
infect
express
also
determin
mechan
drive
alter
express
show
first
time
hbv
infect
increas
express
via
signal
pathway
human
hepatocellular
carcinoma
cell
cultur
dmem
incub
medium
supplement
fb
iuml
penicillin
iuml
streptomycin
cell
chang
fresh
medium
everi
third
day
split
trypsin
confluenc
cell
variant
cell
express
hbv
genom
control
tetracyclin
tet
promot
therefor
cell
cultur
medium
also
contain
tetracyclin
requir
express
hbv
gene
cell
secretori
hbv
cell
line
deriv
viral
antigen
hbsag
hbeag
cultur
medium
measur
use
chemiluminesc
method
commerci
assay
kit
wantai
beij
china
hbv
dna
quantif
assay
perform
use
commerci
realtim
pcr
kit
kehua
shanghai
china
plasmid
contain
seven
individu
viral
gene
hbv
ie
control
plasmid
kind
gift
dr
quan
yuan
tiani
zhang
nation
institut
diagnost
vaccin
develop
infecti
diseas
xiamen
univers
china
transient
transfect
plasmid
perform
use
lipofectamin
reagent
invitrogen
unit
state
accord
manufactur
protocol
cell
line
express
therefor
inhibitor
use
concentr
unless
otherwis
note
sigmaaldrich
ad
cell
h
transfect
human
liver
tissu
obtain
patient
treat
tongji
hospit
tongji
medic
colleg
huazhong
univers
scienc
technolog
juli
decemb
includ
nontumor
sampl
hbvrelat
hcc
patient
sampl
nonhbvrel
hcc
patient
tissu
sampl
collect
store
investig
cell
lyse
h
transfect
cell
tissu
sampl
lyse
rira
sigmaaldrich
buffer
pmsf
sigmaaldrich
lysat
centrifug
min
g
protein
supernat
quantifi
use
bca
method
pierc
sdspage
western
blot
analysi
perform
accord
standard
procedur
mous
antihb
antihbx
antihbp
antihbc
antibodi
kindli
provid
dr
quan
yuan
xiamen
univers
goat
santa
cruz
dilut
rabbit
proteintech
dilut
rabbit
genetex
dilut
mous
abcam
dilut
antibodi
use
primari
antibodi
mous
proteintech
dilut
use
refer
protein
quantif
goat
antimous
igg
proteintech
dilut
goat
antirabbit
igg
proteintech
dilut
donkey
antigoat
igg
santa
cruz
dilut
use
secondari
antibodi
follow
enhanc
chemiluminesc
ecl
thermofish
scientif
detect
ethic
committe
tongji
hospit
tongji
medic
colleg
huazhong
univers
scienc
technolog
author
studi
protocol
written
inform
consent
obtain
particip
regard
aim
object
studi
irb
id
valid
date
data
mean
sd
least
three
replic
express
level
compar
group
use
student
test
statist
analysi
perform
use
spss
softwar
differ
consid
statist
signific
valu
p
order
investig
whether
hbv
could
upregul
express
measur
express
hepatoma
cell
without
hbv
transfect
protein
level
cell
line
stabl
hbvtransfect
higher
cell
figur
confirm
whether
hbv
infect
caus
upregul
cell
express
hbv
genom
control
tetracyclin
tet
promot
investig
express
hbv
gene
cell
line
restrict
presenc
tet
tet
absent
cell
produc
kb
hbv
pregenom
rna
secret
viruslik
particl
supernat
found
express
cell
without
tet
higher
cell
tet
figur
b
express
level
mannosidas
higher
cell
cell
turn
greater
cell
investig
associ
express
viru
secret
assess
viru
secret
cell
cultur
supernat
variou
hbv
cell
line
among
three
cell
line
without
tet
show
highest
secret
hbvdna
iuml
hbeag
ncuml
hbsag
iuml
figur
express
cell
line
posit
correl
express
hbsag
figur
next
investig
whether
hbv
could
upregul
express
human
liver
sampl
level
nontumor
liver
tissu
hbvrelat
hcc
patient
higher
tissu
nonhbvrel
hcc
patient
figur
find
suggest
hbv
increas
express
vivo
vitro
sinc
previou
studi
shown
play
vital
role
glycosyl
subsequ
experi
focus
role
protein
repres
confirm
effect
hbv
express
plasmid
contain
seven
individu
viral
gene
hbv
control
plasmid
transfect
cell
western
blot
use
determin
express
hbx
figur
hbp
figur
hbc
figur
hb
figur
wherea
elisa
use
estim
express
hbe
figur
protein
level
increas
cell
transfect
hb
howev
viral
protein
hbc
hbx
hbe
hbp
signific
effect
express
figur
g
hbv
gene
three
envelop
protein
shb
mhb
lhb
similar
shb
motif
shb
mhb
lhb
focus
studi
downregul
express
revers
activ
ppar
signal
pathway
investig
whether
hbvinduc
increas
express
associ
ppar
signal
pathway
cell
express
inhibitor
use
explor
effect
hbv
express
pathway
block
result
show
applic
inhibitor
effect
hbv
express
neutral
howev
effect
found
inhibitor
appli
figur
order
confirm
whether
ppar
signal
pathway
play
role
hbvmediat
increas
level
test
effect
express
cell
found
affect
express
cell
without
tet
indic
inhibit
increas
level
caus
tet
withdraw
howev
phenomenon
observ
case
figur
envelop
virus
includ
hbv
contain
envelop
protein
polysaccharid
extens
glycosyl
protein
glycosyl
multipl
function
sometim
assist
evad
immun
surveil
virus
use
host
cell
glycosyl
system
synthes
modifi
envelop
proteoglycan
thu
structur
viral
envelop
glycoprotein
affect
glycosyl
mechan
host
inde
previou
studi
shown
appli
lowdos
glucosidas
inhibitor
host
cell
chang
phenotyp
viral
envelop
protein
turn
reduc
viral
infect
affect
viru
assembl
andor
particl
releas
exampl
inhibitor
nbdnj
previous
shown
prevent
hbv
correct
fold
releas
viral
envelop
molecul
thu
could
dosedepend
reduc
viru
level
hand
inhibitor
kifunensin
affect
product
secret
hbv
viru
particl
increas
recognit
dcsign
result
activ
immun
respons
moreov
previou
studi
found
demannosyl
benefici
hbv
escap
dcsign
recognit
therefor
upregul
host
hbv
observ
studi
appear
contribut
viral
escap
hbv
contain
three
envelop
protein
made
domain
larg
l
middl
small
envelop
protein
l
protein
singli
glycosyl
l
protein
protein
also
nglycosyl
site
nxst
region
hand
protein
biglycosyl
site
use
plasmid
encod
differ
hbv
protein
includ
l
protein
transfect
cell
surprisingli
found
l
protein
could
increas
express
howev
effect
found
hbv
protein
l
protein
includ
domain
hypothes
region
induc
increas
therefor
protein
use
repres
envelop
protein
consequ
experi
unclear
whether
envelop
protein
increas
express
via
direct
indirect
effect
investig
exact
mechan
involv
hbvinduc
express
examin
whether
hbv
envelop
protein
activ
pathway
increas
express
protein
howev
found
inhibit
pathway
affect
hbv
envelop
proteininduc
upregul
express
hand
pathway
inhibit
envelop
protein
could
upregul
express
result
indic
express
associ
pathway
wherea
previou
studi
shown
express
endotheli
cell
associ
pathway
specul
express
ppar
subtyp
could
alter
differ
cell
type
could
least
partial
respons
differ
find
previou
studi
also
test
effect
express
cell
increas
level
inhibit
cell
therefor
specul
effect
hbv
envelop
protein
upregul
express
class
close
associ
pathway
focus
studi
furthermor
measur
hbv
glycosyl
statu
togeth
effect
hbv
glycosyl
upon
knockdown
differ
mannosidas
member
hbv
express
cell
might
better
explain
correl
hbv
product
mannosidas
level
hbv
glycosyl
statu
consid
mannosidas
member
explain
correl
hbv
product
mannosidas
level
hbv
glycosyl
statu
futur
experi
conclus
find
present
studi
show
hbv
could
increas
express
class
vitro
vivo
moreov
hbv
envelop
protein
increas
express
class
via
pathway
figur
find
suggest
class
could
use
drug
target
inhibit
demannosyl
hbv
therebi
improv
bind
viru
dcsign
disrupt
immun
toler
prevent
treat
viral
infect
would
like
thank
professor
xiaop
chen
tongji
hospit
tongji
medic
colleg
huazhong
univers
scienc
technolog
provid
liver
sampl
mr
quan
yuan
tiani
zhang
xiamen
univers
provid
cell
plasmid
hepat
b
viru
hbv
infect
common
chronic
viral
infect
world
estim
billion
peopl
infect
million
chronic
carrier
viru
studi
investig
effect
hbv
express
class
tumor
necrosi
shown
downregul
express
increas
express
highmannos
type
proteoglycan
revers
activ
ppar
signal
pathway
base
result
previou
studi
author
hypothes
hbv
could
promot
demannosyl
viral
protein
increas
express
host
cell
class
could
use
drug
target
inhibit
demannosyl
hbv
prevent
immun
toler
viru
author
consid
mannosidas
member
explain
correl
hbv
product
mannosidas
level
hbv
glycosyl
statu
futur
experi
hbv
infect
common
chronic
viral
infect
worldwid
insuffici
immun
respons
hbvinfect
patient
develop
chronic
hepat
possibl
liver
cirrhosi
hepatocellular
carcinoma
present
studi
author
aim
explor
one
mechan
abl
impair
dendrit
cell
function
patient
suffer
chronic
hepat
b
hypothes
hbv
could
promot
demannosyl
hbv
glycoprotein
coat
increas
express
allow
hbv
escap
host
immun
